{"id":923121,"date":"2025-12-31T07:34:54","date_gmt":"2025-12-31T12:34:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/"},"modified":"2025-12-31T07:34:54","modified_gmt":"2025-12-31T12:34:54","slug":"profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/","title":{"rendered":"Profusa Bolsters European Commercial Network with New French Distributor, MedSell"},"content":{"rendered":"
\n

\n MedSell commercializes Lumee\u2122 Oxygen tissue monitoring in France, building upon distributor partnerships in Spain, Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia, to now reach approximately 200,000 annual CLI cases in the European Union <\/i>\n <\/p>\n

\n Agreement complements KOL collaboration with Vascular Center at Groupe Hospitalier Paris Saint Joseph, Paris that accounts for approximately 8% of all CLTI cases in France<\/i>\n <\/p>\n

BERKELEY, Calif, Dec. 31, 2025 (GLOBE NEWSWIRE) — Profusa, Inc. (\u201cProfusa\u201d or the \u201cCompany\u201d) (Nasdaq: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual\u2019s biochemistry, announces a new distributor partnership in France with MedSell.\u00a0 MedSell is a French company that specializes in the commercialization and distribution of innovative medical devices within the French healthcare market by leveraging tailored commercial, marketing, and market-entry support services.\u00a0 As part of its portfolio, Profusa\u2019s new partner will commercialize Lumee Oxygen tissue monitoring in France in both hospital settings and outpatient care, especially in wound care and healing clinics addressing patients with complex and chronic wounds.<\/p>\n

Benoit Sala\u00fcn, Pharm.D., Ph.D., MedSell General Manager, said, \u201cOur collaboration with Profusa stems from our particular interest in Lumee Oxygen tissue monitoring for the large population of patients in France with Critical Limb Threatening Ischemia (CLTI). The device enables the measurement of tissue oxygen perfusion before revascularization, during endovascular or open surgical procedures, and throughout follow-up in hospitals or wound care clinics. We believe Lumee Oxygen tissue monitoring meets a critical unmet clinical need and can bring significant added value to clinicians by supporting decision-making and patient monitoring across the entire treatment pathway.\u201d<\/p>\n

With MedSell, Profusa builds upon previously announced distributor partnerships in Spain, Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia, to now represent more than 200,000 CLI cases annually in the European Union.\u00a0 Further, the distribution partnership with MedSell complements Profusa\u2019s previously announced collaboration with Yann Gou\u00ebffic, M.D., Ph.D., professor of vascular surgery in the Vascular Center at Groupe Hospitalier Paris Saint Joseph<\/a>, Paris, France and a leading surgeon in the field of critical limb threatening ischemia (CLTI). Under the agreement, Pr. Gou\u00ebffic adopts Lumee\u2122 oxygen monitoring technology in his practice and in clinical studies that advance application of Lumee for home monitoring. Pr. Gou\u00ebffic and his associated practices account for approximately 8% of all CLTI cases in France.<\/p>\n

“We are focused on executing on our commercial strategies, including plans to potentially achieve $200 to $250 million in revenue by 2030; capitalize on the near-term as we begin to commercialize in Europe in 2Q 2026<\/a> \u00a0with the goal of addressing the US Lumee oxygen opportunity in 2027.\u00a0 We expect to deliver 2026 potential revenue of $0.5 to $2 million<\/a> and $9 to $13 million potential revenue in 2027,\u201d said Ben Hwang, Ph.D., Profusa\u2019s Chairman and CEO.\u00a0 \u201cThe European clinical community continues to validate our Lumee Oxygen tissue monitoring, including recent presentations of US-based clinical trial data at Paris Vascular Insights<\/a> and Leipzig Interventional Course<\/a>.\u00a0 We are committed to making our oxygen tissue monitoring platform easily accessible both at the clinic and at home to improve overall patient outcomes and reduce healthcare costs.\u201d<\/p>\n

\n About Profusa<\/b>\n <\/p>\n

Based in Berkeley, Calif., Profusa is a commercial stage digital health company led by visionary scientific founders, an experienced management team and a world-class board of directors in the development of a new generation of tissue-integrated sensors to detect and continuously transmit actionable, medical-grade data for personal and medical use. With its long-lasting, injectable and affordable biosensors and its intelligent data platform, Profusa aims to provide people with a personalized biochemical signature rooted in data that clinicians can trust and rely on.<\/p>\n

\u201cLUMEE\u201d, \u201cPROFUSA\u201d and the PROFUSA logo are registered trademarks of Profusa Inc. in the United States, Canada, European Union, China, Japan, South Korea and Australia.<\/p>\n

For more information, visit\u00a0https:\/\/profusa.com.<\/a><\/p>\n

\n Special Note Regarding Forward-Looking Statements<\/b>\n <\/p>\n

Certain statements in this press release (this \u201cPress Release\u201d) may be considered \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or future financial or operating performance of Profusa. In some cases, you can identify forward-looking statements by terminology such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cforecast,\u201d \u201cfuture,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpossible,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cpropose,\u201d \u201cseek,\u201d \u201cshould,\u201d \u201cstrive,\u201d \u201cwill,\u201d or \u201cwould\u201d or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which may be beyond the control of Profusa and could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Profusa and its management are inherently uncertain. Profusa cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. There are risks and uncertainties described in the definitive proxy\/final prospectus relating to the business combination, which has been filed with the SEC, and in other documents filed by Profusa from time to time with the SEC. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Profusa cannot assure you that the forward-looking statements in this communication will prove to be accurate.<\/p>\n

\n Contacts<\/b>
\n
\n Investor and Media Contacts<\/b>
\n
email:\u00a0 info@coreir.com<\/a>
phone:\u00a0 1 (212) 655-0924<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

MedSell commercializes Lumee\u2122 Oxygen tissue monitoring in France, building upon distributor partnerships in Spain, Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia, to now reach approximately 200,000 annual CLI cases in the European Union Agreement complements KOL collaboration with Vascular Center at Groupe Hospitalier Paris Saint Joseph, Paris that accounts for approximately 8% of all CLTI cases in France BERKELEY, Calif, Dec. 31, 2025 (GLOBE NEWSWIRE) — Profusa, Inc. (\u201cProfusa\u201d or the \u201cCompany\u201d) (Nasdaq: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual\u2019s biochemistry, announces a new distributor partnership in France with MedSell.\u00a0 MedSell is a French company that specializes in the commercialization and distribution of … <\/p>\n

Continue reading “Profusa Bolsters European Commercial Network with New French Distributor, MedSell”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-923121","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nProfusa Bolsters European Commercial Network with New French Distributor, MedSell - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Profusa Bolsters European Commercial Network with New French Distributor, MedSell - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MedSell commercializes Lumee\u2122 Oxygen tissue monitoring in France, building upon distributor partnerships in Spain, Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia, to now reach approximately 200,000 annual CLI cases in the European Union Agreement complements KOL collaboration with Vascular Center at Groupe Hospitalier Paris Saint Joseph, Paris that accounts for approximately 8% of all CLTI cases in France BERKELEY, Calif, Dec. 31, 2025 (GLOBE NEWSWIRE) — Profusa, Inc. (\u201cProfusa\u201d or the \u201cCompany\u201d) (Nasdaq: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual\u2019s biochemistry, announces a new distributor partnership in France with MedSell.\u00a0 MedSell is a French company that specializes in the commercialization and distribution of … Continue reading "Profusa Bolsters European Commercial Network with New French Distributor, MedSell"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-31T12:34:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxODQ0OSM3MzQwMzg2IzUwMDA5ODI1NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Profusa Bolsters European Commercial Network with New French Distributor, MedSell\",\"datePublished\":\"2025-12-31T12:34:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/\"},\"wordCount\":918,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYxODQ0OSM3MzQwMzg2IzUwMDA5ODI1NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/\",\"name\":\"Profusa Bolsters European Commercial Network with New French Distributor, MedSell - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYxODQ0OSM3MzQwMzg2IzUwMDA5ODI1NA==\",\"datePublished\":\"2025-12-31T12:34:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYxODQ0OSM3MzQwMzg2IzUwMDA5ODI1NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYxODQ0OSM3MzQwMzg2IzUwMDA5ODI1NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Profusa Bolsters European Commercial Network with New French Distributor, MedSell\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Profusa Bolsters European Commercial Network with New French Distributor, MedSell - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/","og_locale":"en_US","og_type":"article","og_title":"Profusa Bolsters European Commercial Network with New French Distributor, MedSell - Market Newsdesk","og_description":"MedSell commercializes Lumee\u2122 Oxygen tissue monitoring in France, building upon distributor partnerships in Spain, Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia, to now reach approximately 200,000 annual CLI cases in the European Union Agreement complements KOL collaboration with Vascular Center at Groupe Hospitalier Paris Saint Joseph, Paris that accounts for approximately 8% of all CLTI cases in France BERKELEY, Calif, Dec. 31, 2025 (GLOBE NEWSWIRE) — Profusa, Inc. (\u201cProfusa\u201d or the \u201cCompany\u201d) (Nasdaq: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual\u2019s biochemistry, announces a new distributor partnership in France with MedSell.\u00a0 MedSell is a French company that specializes in the commercialization and distribution of … Continue reading \"Profusa Bolsters European Commercial Network with New French Distributor, MedSell\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-31T12:34:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxODQ0OSM3MzQwMzg2IzUwMDA5ODI1NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Profusa Bolsters European Commercial Network with New French Distributor, MedSell","datePublished":"2025-12-31T12:34:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/"},"wordCount":918,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxODQ0OSM3MzQwMzg2IzUwMDA5ODI1NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/","name":"Profusa Bolsters European Commercial Network with New French Distributor, MedSell - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxODQ0OSM3MzQwMzg2IzUwMDA5ODI1NA==","datePublished":"2025-12-31T12:34:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxODQ0OSM3MzQwMzg2IzUwMDA5ODI1NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxODQ0OSM3MzQwMzg2IzUwMDA5ODI1NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-bolsters-european-commercial-network-with-new-french-distributor-medsell\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Profusa Bolsters European Commercial Network with New French Distributor, MedSell"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/923121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=923121"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/923121\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=923121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=923121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=923121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}